Clinical Evidence for Treating MS
Kim Skinner, PT, DPT
Director of Physical Therapy, Helius Medical Technologies
“As a physical therapist involved in the clinical trials for people with MS, I saw improvements in their gait which many expressed had benefit in daily activities, making things like going to the grocery store and walking outside easier and safer. Many reported that the gait improvement helped them regain a sense of independence, which is often affected by this disease.”
The PoNS™ device was studied in two clinical trials in relation to multiple sclerosis.
In a study of 20 patients with multiple sclerosis, it was shown using the PoNS™ device in combination with physical therapy over 14 weeks led to a significant improvement in gait, as compared to physical therapy alone. 95% of all study patients experienced improvement in their gait however, the PoNS Treatment™ group, on average, had 2x improvement in their gait scores¹.
A neuroimaging study of 14 MS patients tested the effects of non-surgical tongue stimulation using the PoNS™ device, combined with cognitive and physical rehabilitation, on their memory, gait, balance and concomitant changes in the brain. The PoNS Treatment™ group showed significant improvement from the baseline, suggesting that PoNS™ stimulation can enhance motor performance and working memory, while also driving neuroplasticity².
*PoNS is not intended to treat memory impairment. PoNS is intended for use as a short term treatment (14 weeks) of gait deficit due to mild and moderate symptoms from MS.
Where can I find more information?
The Journal of NeuroEngineering and Rehabilitation | May 1, 2014
Multiple Sclerosis Journal Experimental, Translational and Clinical | December 23, 2016
If you are a clinician seeking detailed information regarding the clinical evidence, please contact us.
How do I get in touch with a clinic that offers PoNS TreatmentTM?
PoNS TreatmentTM is exclusively offered by authorized clinics across Canada with more opening soon.
¹Leonard G, et al. Multiple Sclerosis Journal–Experimental, Translational and Clinical. 2017; 3(1):2055217317690561.
²Tyler E, et al. Journal of Neuroengineering and Rehabilitation. 2014; 11(1):79.
Subscribe To Our Newsletter
Sign-up to find out more about:
- PoNS Treatment™ experience from other physical therapists and clinicians
- Future clinics to offer PoNS Treatment™
- New indications
- New publications